FDA Inspection 1235545 - Boehringer Ingelheim Pharmaceuticals, Inc. - May 02, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on May 2, 2024, issued by the New England District Office, covering biologics.

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date: May 2, 2024
Product Type: Biologics
Office: New England District Office

Open in Dashboard

ID · 122bc596-1442-42ff-ae7f-bbbed8bd1ff0